Evidence map›Paper›PMID 26950194›Full record

ReviewVirulence2016

Bloodstream infections in HIV-infected patients.

Lucia Taramasso, Paola Tatarelli, Antonio Di Biagio

Open access · goldAbstract readReview
In one paragraph

Review in Virulence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

  1. Observational
  2. Review
  3. Cryptococcal Endocarditis in Humans-A Narrative Review.Pathogens (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Clinical characteristics of respiratory tract infection caused byFrontiers in cellular and infection microbiology · 2023
    Article
  12. Article
  13. Infection and drug resistance · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Antimicrobial Resistance inFrontiers in medicine · 2021
    Review
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Lucia Taramassoa Infectious Diseases Unit, IRCCS AOU San Martino-IST, University of Genoa , Genoa , Italy.
Paola Tatarellia Infectious Diseases Unit, IRCCS AOU San Martino-IST, University of Genoa , Genoa , Italy.
Antonio Di Biagioa Infectious Diseases Unit, IRCCS AOU San Martino-IST, University of Genoa , Genoa , Italy.
Ospedale Policlinico San Martino · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the combined antiretroviral therapy era, HIV-infected patients remain a vulnerable population for the onset of bloodstream infections (BSI). Worldwide, nontyphoid salmonellae, Streptococcus pneumoniae, Escherichia coli, Staphylococcus aureus and coagulase negative staphylococci are the most important pathogens. Intravenous catheter associated infection, skin-soft tissue infection and endocarditis are associated with Gram-positive bacteremia. Among the Gram-negative, nontyphoidal Salmonella have been previously correlated to sepsis. Other causes of BSI in HIV-infected patients are mycobacteria and fungi. Mycobacteria constitute a major cause of BSI in limited resource countries. Fungal BSI are not frequent and among them Cryptococcus neoformans is the most common life-threatening infection. The degree of immunosuppression remains the key prognostic factor leading to the development of BSI.

Indexed as

BacteremiaCryptococcus neoformansEndocarditis, BacterialEscherichia coliFemaleFungemiaFungiHIV InfectionsHumansImmune ToleranceMaleMiddle AgedMycobacteriaceaeSalmonellaStaphylococcus aureusAIDSbacteriemiabloodstream infectionBSIfungemiaGram negativeGram positiveHIVmycobacteriasepsis

Identifiers

PMID26950194
PMCPMC4871667
OpenAlexW2296551319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.